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Mesenchymal stem cells, characterized by their ability to differentiate into
skeletal tissues and self-renew, hold great promise for both regenerative
medicine and novel therapeutic discovery. However, their regenerative
capacity is retained only when in contact with their specialized microenvir-
onment, termed the stem cell niche. Niches provide structural and functional
cues that are both biochemical and biophysical, stem cells integrate this com-
plex array of signals with intrinsic regulatory networks to meet physiological
demands. Although, some of these regulatory mechanisms remain poorly
understood or difficult to harness with traditional culture systems. Biomater-
ial strategies are being developed that aim to recapitulate stem cell niches, by
engineering microenvironments with physiological-like niche properties that
aim to elucidate stem cell-regulatory mechanisms, and to harness their
regenerative capacity in vitro. In the future, engineered niches will prove
important tools for both regenerative medicine and therapeutic discoveries.1. Introduction
Mesenchymal stem cells (MSCs) have the ability to both self-renew and differ-
entiate, yielding daughter cells that are essential for tissue maintenance and
repair. Unlike embryonic stem cells (ESCs), MSCs must tightly balance special-
ization in response to regenerative demand and retention of a stem cell pool
throughout life and this balance is controlled by the niche environment e.g.
the bone marrow [1]. Further, perhaps because of their pericyte/perivascular
origin [2], MSCs have the ability to suppress the immune response and
reduce inflammation. These properties make MSCs ideal therapeutic candi-
dates. Potential clinical applications are wide ranging, from underpinning
tissue regeneration for the treatment of trauma (tissue engineering/regenerative
medicine [3,4]) to novel cancer therapies (homing to tumours [5] and then deli-
vering drug/gene therapies [6,7]) and new transplant protocols (providing
immune-suppressed environments allowing tissue engraftment [8–10]).
However, since their discovery in 1974 [11] there have been less clinical suc-
cess stories than first imagined for MSCs, currently there are only a small
number of other adult stem cell (ASC) therapies approved in the clinic. Perhaps
of greatest success, are bone marrow transplants which for over 50 years have
been harbouring haematopoietic stem cells (HSCs) to treat leukaemia and lym-
phoma patients, and more recently autoimmune diseases such as multiple
sclerosis [12]. In 2015, the use of limbal stem cells from the eye were approved
in Europe to repair cornea injury and restore sight [13].
MSCs are easily harvested from autologous bone marrow, fat or umbilical
cord and have shown promise in vitro and in vivo with their ability to form
bone and cartilage as well as through their immunomodulatory capacity;
indeed, this capacity is finding use in e.g. islet transplant procedures [14].
Autologous MSC-based products, e.g. PREOB and Bonofill are in advanced
clinical trials. Further, companies are starting to look to market allogenic
MSC-based products, such as Trinity ELITE/Evolution, AlloStem, Osteocel
Plus, Cellentra VCBM.
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Box 1. Model of the organization of stem cells and tissue-specific mesenchymal progenitors. Multipotent stem cells exist in homeostasis between
quiescence and an activated state. Activation, and entry to the cell cycle, occurs upon tissue damage or other physiological stimuli. Upon activation
(regenerative demand), multipotent progenitor cells with transit amplification capacity arise. These progenitors are the precursors to the tissue-
specific mature cells, for example osteoblasts, adipocytes and chondrocytes in the mesenchymal stem cell compartment. The activated stem cell and
its daughter cells differentiate or can return to a quiescent state once the tissue repair or other physiological process is complete. This homeostasis
between quiescence and self-renewal is tightly regulated to avoid transformations and to retain a viable stem cell pool throughout the life of the
organism [15]. (Online version in colour.)
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proliferation, self-renewal and quiescence through cell-
intrinsic regulatory networks (box 1). However, only in
concert with their specialized microenvironment do they
retain their unique properties. This local microenvironment
is termed the stem cell niche. First described four decades
ago by Schofield [16], it refers to the extrinsic physical and
functional factors that feedback to mediate cell behaviour.
ASC niches have been identified in multiple human tissues,
including HSCs in the bone marrow [17], neural stem cells
in the subgranular and subventricular zones [18], epidermal
stem cells in the hair follicle [19,20] and corneal limbus [21]
and intestinal stem cells (ICSs) in the base of the epithelial
crypt [22]. The perivascular origin of MSC is likely the
factor that means that MSCs are found in different anatomical
locations e.g. bone marrow, adipose tissue and close to the
corneal limbus [2].
Model organisms have served as excellent tools for inves-
tigating stem cell niches, however they do not convey the
complexity of the mammalian niches that have proven
difficult to access and visualize, leaving many niches incom-
pletely defined [23]. Mechanistic studies on model systems,
such as Drosophila melanogaster and Caenorhabditis elegans,
allow combinatorial approaches of molecular, genetic,
systems and cell biology methods that have contributed
greatly to understanding stem cell behaviours. Drosophila
offer simple experimentation on well-characterized structures
such as the fly gonad, which contains a niche environment
with germ-line stem cells that are actively dividing. Owing
to genetic and cell-biological methods that are uniquely avail-
able to fly biologists these simple systems render powerful
tools. How similar fly and mammalian niches are would ulti-
mately require parallel understanding of structures and
functions, however some similarities can be drawn, forexample, from conserved signalling pathways and cell
types that will ultimately prove key for underpinning
mechanisms in the mammalian niche [23,24].
Many challenges remain about what niche components
are fundamental for retaining stem cell properties—how
and what is being controlled, and for what purpose? Aims
to address these challenges rely on advances in technologies
that will allow the recapitulation of the niche outside of the
body. Such technologies will offer greater insight into com-
ponents, and cell-intrinsic and extrinsic interactions that
regulate stem cells in specific microenvironments. This will
allow us to understand what questions we need to answer
to exploit these cells using biotechnological expansion
approaches for therapeutic potential. As biomaterial technol-
ogies advance, answers to these questions are being
elucidated, with the ability to construct and manipulate ‘de
novo’ niches and harness the differentiation potential of
stem cells.
Biomaterial (surfaces, tissue engineering scaffolds), bio-
fabrication (microfluidics, three-dimensional bioprinting)
and bioreactor (physiological environment) techniques hold
the potential to allow us to construct, deconstruct and
investigate the important components of cellular microenvir-
onments. Such approaches could evolve the development of
both reductionist stem cell interfaces allowing high through-
put analysis and discovery and, perhaps more importantly,
non-animal technologies (NATs) that recreate tissue complex-
ity and reduce costly/inefficient animal experimentation. The
challenges, however, are great. The niche, as highlighted in
figure 1, is a complex environment. It is notable that in
small molecule drug discovery, the drive for high through-
put, overly simplified cell models that do not recreate cell
niches and animal testing in non-human models have fuelled
the productivity crisis where large numbers of drug
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Figure 1. Parameters of the stem cells and their niches. Niches are multi-factorial and complex microenvironments that are unique and specific to function, however
many principle parameters of niches are shared. Generally, they are comprised of physical and dynamic factors such as heterologous cellular components and cell–
cell interactions, soluble and secreted or membrane bound factors, immunological activation and response, extracellular matrix (ECM) protein components and
structures, physical architectural parameters, oxygen tension and metabolic control. Adapted from reference [25]. (Online version in colour.)
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in clinical trial. Only 43% of fails are not predicted by tra-
ditional in vitro and pre-clinical in vivo screens and move
into clinical trials [26]. This is driving Pharma to look to
NATs [27], built using human cells and likely requiring the
tissue complexity that stem cells can produce. Such systems
that can be used to predict drug mechanism, toxicity and effi-
cacy require understanding of cell (stem cell) niche
environments and techniques borrowed from regenerative
medicine to direct the cells.
Here we review recent progress in the area and give a for-
ward look on the development of artificial niches, with
particular focus on MSCs. First, we discuss how biomaterial
technologies have developed our understanding of cell–
substrate interactions, and consider important factors in a
cells’ niche that allow us to differentiate stem cell populations
for potential use in regenerative medicine. We then discusshow this understanding has led to recent advances in harnes-
sing the capacity of stem cell self-renewal for prospective use
in stem cell transplants and for immunosuppression. Finally,
we provide an outlook on how combinations of such tech-
niques provide opportunities for the generation of complex
artificial stem cell niches.2. Differentiation
Stem cell niches maintain self-renewal/quiescence [28]. How-
ever, this dynamic and multicellular environment must also
signal for differentiation as part of regenerative processes.
Cues in these environments are complex. Mechanical [29],
physical [30], chemical [31], spatial [32] and temporal [33]
cues ranging across many magnitudes—for example from
subcellular level forces from the extracellular matrix (ECM),
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To understand how properties of the biomaterial interface,
such as stiffness, topography and chemistry can regulate
cell behaviour, we must first consider how cells adhere to
substrates. The architecture of a cell’s microenvironment con-
tains stimuli ranging from the micro to the nanoscale;
microscale features are in the range of the size of the cell
itself and result in whole-cell responses such as alignment
of cells with topographical features, known as contact gui-
dance [35]. However, nanoscale features present a
multitude of cues that are several orders of magnitude
below that of the cell [32].
Cell adherence to substrates is typically through integrins,
transmembrane receptors that tether to the ECM, which itself
forms an intermediate layer of proteins adsorbed on the sur-
face of materials exposed to serum [36,37]. Integrins are
heterodimeric proteins (containing a- and b-subunits) that
ligate to peptide motifs on ECM proteins, for example the
arginine, glycine and aspartic acid (RGD) tripeptide [38].
These interactions cause intracellular signalling cascades,
typically G protein activation leading to phosphorylation of
myosin light chain kinase (MLCK) through Rho-associated
protein kinase (ROCK), increasing actin–myosin contractility
causing integrin clustering and cell adhesion formation
[39,40]. Adhesion formation is dynamic, cells use unbundled,
actin-driven membrane projections, filopodia, to probe the
external environment. It has been shown that filopodia can
follow contact guidance cues down to 10 nm in height [41].
At the sub-10 nm height scale nanoscale projections have
been detected, evidencing the great sensitivity of cellular sen-
sing. It is noteworthy that at this sub-10 nm scale, contact
guidance was not observed, just feature interactions [42].
Control over adhesion size has been achieved using litho-
graphy strategies to create nanopatterned substrates with
controlled size, shape, spacing and symmetry in a variety
of materials; patterns have included nanopits [43–45],
nanopillars [46] and nanogrooves [47]. Control of these
nano-features allows control over adhesion size, number
and spacing. It has been shown that large, super-mature,
adhesions (greater than 5 mm long) are required for osteogen-
esis of MSCs [48]. By creating substrates that promote
increased adhesion size, intracellular tension is also increased
and this conformational change is linked to mechanical
changes in the cytoskeleton, which can transfer tensile (contrac-
tile) forces to the nucleus, perhaps via cytoskeletal tensegrity
[49,50], and increased intracellular tension is linked to osteo-
genesis [48]. Such changes in nucleus shape can consequently
affect chromosomal arrangements [51–53], and these changes
can potentially impact stem cell phenotype [54].
Such alterations in cell adhesion, cytoskeletal organiz-
ation and mechanotransductive cell fate changes are likely
to be driven by the topography–protein interface. Indeed, if
fibronectin (FN), a major cell-adhesive protein of the ECM
is absorbed onto nanopit patterned surfaces, FN adsorbs
within the pits and it was seen that cells probed these pits
with filopodia, leading to ‘nanoimprinting’ of the pits on
the cell membrane, an effect that was not observed when
the substrate was not coated in FN [55]. Nanoimprintinghas been shown to be cell-adhesion mediated, with adhesion
to topographical features leading to mimics of the topogra-
phy in the basal cell cytoskeleton [56]. If the integrins are
blocked then nanoimprinting cannot occur [56], indirectly
demonstrating the importance of the ECM on cell response
to shape. This suggests that the topography-driven changes
in cell cytoskeleton organization and adhesion are mediated
by protein adhesive interface and cells interact with this
interface dependent on the topography [55].
Cell adhesion and subsequent spreading that governs size
and shape influence physiological processes such as cell sur-
vival [57]. Using microcontact printed ECM islands of
decreasing size, it has been shown that cell confinement gov-
erns control over growth and death, with small areas that
restrict spreading leading to apoptosis [57]. Since then, this
technique has been employed to confine MSCs in specific
morphologies, controlling adhesion and intracellular tension
[39,40]. On ECM islands/shapes where the MSCs remained
rounded, they were unable to form mature adhesions, lead-
ing to adipogenic lineage commitment. By contrast, ECM
islands/shapes and sizes that allowed spreading, promoted
actin–myosin contractility and mature adhesion formation
drove MSCs to undergo osteogenesis [39,40]. The actomyosin
tension of the cytoskeleton contributes to this geometric con-
trol, which is biophysically linked through adhesion
formation governed at the nanoscale by changes in plasma
membrane. It is thus further notable that modulation of the
plasma membrane lipid assembly can regulate intracellular
signalling and thus stem cell fate [58].
Topographical RGD coupled substrates have been used to
decouple adhesion requirements for cell spreading. As integ-
rins ligate, they are coupled to the actin cytoskeleton.
Through activation of G-proteins inducing actin–myosin con-
traction, the integrins are gathered together leading to mature
adhesion formation comprising many integrins. Using nano-
colloid particles with one RGD motif covalently linked to
each colloid, it has been demonstrated that when RGD is at
a density of less than 70 nm apart, integrin gathering can
occur; above this density integrins cannot gather together
and form mature adhesions [59,60]. Using electron beam
lithography approaches to create groups (dimers to hepta-
mers) of RGD within 70 nm of each other, it was found that
the small clusters separated beyond gathering distance,
whereas tetramers of gathered integrins were required for
complete cell spreading—i.e. functional adhesions [61].
This topographical control over how cells adhere to sub-
strates has been used to control either self-renewal or
osteogenic differentiation of MSCs, using topographies that
can be remarkably similar. For example an electron beam
lithographically defined pattern that permits out-of-niche
self-renewal is comprised of pits with a diameter of 120 nm,
depth of 100 nm and centre–centre spacing of 300 nm in a
square lattice (SQ) [44]. Adding just +50 nm offset from
the centre position, changing the surface to near-square
(NSQ) changes MSC fate to osteogenesis [45]. As noted
above, adhesion size is quite different on each surface, with
MSCs forming smaller adhesions and less intracellular ten-
sion on SQ compared to NSQ [43] (figure 2). It is
interesting to note that cells on the NSQ surface change
their endogenous ECM output from FN to vitronectin [62].
Vitronectin has been associated with increasing cells’ ability
to bridge gaps in the ECM, this means that if enough integ-
rins are gathered in two close locations, intracellular linker
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Figure 2. Topography to control MSC adhesion for self-renewal and osteogenesis. (a) Self-renewing MSCs adhere more-weakly than osteo-committed cells, leading
to lower levels of integrin-mediated signalling through focal adhesion kinase (FAK), retaining levels of extracellular signal-regulated kinase (ERK1/2) to support
growth but not differentiation. (b) MSCs undergoing osteogenesis require larger adhesions, increased FAK activation elevates ERK1/2 activation to levels required
for lineage commitment, increasing intracellular tension, activating Runt-related transcription factor 2 (RUNX2), a key regulator of osteogenesis, while simultaneously
inactivating adipogenic regulator peroxisome proliferator-activated receptor gamma (PPAR-y). Fluorescent images show a marked increase in adhesion size on near
square (NSQ) compared with square (SQ) surfaces. Adapted from reference [43]. Copyright & 2018 American Chemical Society. (Online version in colour.)
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two locations, even if there are no integrin ligands present
in the gap; this is called bridging and vitronectin is a more
effective bridging protein than FN [63]. We further note
that the ECM is a complex mixture of proteins and that inter-
action with other receptors can also elicit changes. For
example, the HAVDI sequence (histidine, alanine, valine,
aspartic acid, isoleucine) can interact with cadherin receptors,
key factors in cell–cell adhesion, and cause loss of intracellu-
lar tension, even in the presence of abundant RGD, through
blocking the g-protein RAC [64,65] (figure 3b).
Osteogenic nanotopographies were originally developed
with orthopaedic implants in mind, where patterns alone
would guide cell fate. Such implants are typically made
from titanium and its alloys. For example, hip replacements
are stabilized by stems into the bone marrow of the femoral
canals. The bone marrow, once disrupted, can no longer func-
tion effectively as a niche and the stem cells differentiate in
response to the implant, but mainly into soft tissue forming
fibroblasts. Fibroblasts are the default differentiation of the
MSC, with MSCs originally identified as fibroblastic colony
forming units [67]. This soft tissue encapsulation leads to
micromotion and ultimately implant failure. It is thus notable
that topographical features that drive osteogenesis, such as
disordered (but not random) nanoscale patterns developed
using electron beam lithography in polymer substrates have
gone on to be featured in titania (the oxide of titanium)
using polymer demixing to provide disordered masks for
anodization processes [68–70]. It is further notable that
such topographies retain osteogenic properties as they trans-
late into metals [71,72]. However, better implant integration
is only one problem with orthopaedic implants—infection
is perhaps a greater problem and can lead to catastrophic
implant failure. It is thus notable that bactericidal nanotopo-
graphies have started to be developed using high-aspect rationanofeatures [73]. Such nanofeatures can be tuned to support
osteogenesis as well as kill bacteria [74], especially if the topo-
graphical approach is twinned with chemistries that can
facilitate enhanced eukaryotic cell adhesion in order to also
promote bone formation [75].2.2. Mechanics
The ECM and surrounding cell junctions have a major phys-
ical influence in transmitting forces between cells, which
ultimately regulate intracellular signalling pathways and
therefore fate [29,66,76,77]. Cells can intrinsically generate
mechanical forces within their environment, for example
actin–myosin contractility leading to matrix remodelling
[78,79]. Equally, mechanical force can come from extrinsic
sources, such as tensile, compressive forces or shear stresses
[29]. Whether individually or collectively, these mechanical
forces impact and regulate cellular behaviour.
Intrinsic and extrinsic mechanical forces guide early
embryo development, even from as early as the blastocyst
stage, when remodelling of cell–cell junctions is driven by
intrinsic cell forces to relieve tension as the embryo transitions
through germ-band elongation. This remodelling of junctions
is not determined by external forces at tissue boundaries but
rather depends on myosin II-dependent spatial reorganiz-
ation leading local forces at cell boundaries [80]. Later in
development, the mechanical properties of the ECM regulate
organ morphogenesis and development, where cell layers are
organized into defined structures by traction forces on the
ECM providing the template for organ growth [29]. This
remodelling and development continues into adulthood as
tissues maintain structure and function. One recent study
highlighted how epidermal stem cells regulate this process
through biomechanical signalling, where local crowding
from dividing stem cells deforms cell shape and stress
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Figure 3. MSC mechanosensing of ECM stiffness cues. (a) Cell mechanosensing through integrin–ECM (in this case fibronectin RGD domain) detect changes in
underlying matrix stiffness, as matrix stiffness increases so does the cytoplasmic-to-nuclear import of Yes-associated protein and its transcriptional co-activator (YAP/
TAZ). YAP/TAZ is a master transcriptional regulator of many functional downstream effects, including differentiation of MSCs. MSCs will preferentially differentiate
into osteoblasts on stiff matrices, and soft tissue types (such as adipose tissue) on soft matrices, hence increased nuclear import of YAP/TAZ on stiff substrates
attenuates osteogenic differentiation of MSCs. In MSCs that are preconditioned on a stiff substrate, and then re-plated to a softer substrate, YAP/TAZ signalling
remains active, and the cells remain committed to an osteogenic differentiation profile, i.e. they retain mechanical memory. (b) Modification of materials to contain
specific peptide sequences can modulate mechanosensitive pathways. By addition of N-cadherin-based interactions, that mimic cell– cell contact (HAV motif—
histidine, alanine and valine), pathways triggered by soft substrates are activated, and the contractile state of the cell is reduced. Whereas integrin-based interactions
mimic cell–ECM contact (RGD—arginine, glycine and aspartic acid), leading to focal adhesion formation, which generates intracellular tension. HAV/N-cadherin
interactions inhibit Rac-GTP levels, decreasing myosin IIA–actin interactions, reducing the recruitment of proteins to integrins to form focal adhesions, and hence
reducing the contractile force generation on the cytoskeleton. Cells thereby behave as though on a softer substrate if HAV/N-cadherin ligation is present. In three-
dimensional materials, peptide modifications such as this can mediate control over osteogenic or chondrogenic differentiation. Chondrocytes typically reside in pairs,
meaning cell– cell interactions are preferable to cell–matrix interactions, i.e. presence of cadherin binding sites leads to chondrogenesis. Adapted from references
[65,66]. (Online version in colour.)
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cell [77]. Owing to the complexity of this communication
between cells and the environmental mechanical milieu, bio-
material strategies have played a key role in elucidating how
these cues affect stem cell behaviour. By deconstructing com-
plex environments and taking early reductionist approaches
we are beginning to understand how mechanical force
regulates cell behaviour.
Much research on MSCs, has previously been carried out
on tissue culture plastic, or on other stiff and planarsubstrates. However, many stem cell niches often have low
stiffness and are three-dimensional. Hydrogel systems are
optimal for investigating mechanobiology due to their
unique properties. Natural or synthetic polymers can be
physically or chemically cross-linked in a controlled manner
to produce hydrogel systems with tuned degradability,
hydrophilicity and stiffness. The water that fills the space
between the macromolecules leads to a degree of flexibility
similar to that of natural tissues, making them both biocom-
patible and biomimicking [81]. Thus, hydrogels provide
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substrates that are more physiological-like. Original work
from Engler et al. used polyacrylamide (PAM) gels of tune-
able matrix stiffness to guide stem cell fate through distinct
tissue lineages; neural at 1 kPa, muscle at 12 kPa and bone
at 30 kPa. This simple tuneable system has somewhat set the
pace over the last decade for the unravelling and exploiting
the biological mechanisms linked to mechanoregulation of
MSCs [82]. Recent studies show stiffness also plays a role in
cell migration [83], proliferation [84] and spreading [85].
Physiological interfaces in vivo exhibit gradients of stiff-
ness, such as those at tissue junctions or at pathological
boundaries, e.g. neuromuscular junctions and the tumour
boundary [86]. Isolated cells are known to migrate to regions
of different stiffness, ‘durotaxis’, the axis of migration
depends upon the cell type; with stem cells known to migrate
to regions of increasing stiffness [87,88]. Cancer cell lines,
meanwhile, have been shown to have a variable relationship
with substrate stiffness [89,90]. Multicellular clusters exhibit
durotaxis, even if isolated cells do not. Groups of epithelial
cells were found to migrate towards stiffer regions—cells
atop stiffer substrate are able to gain better traction than on
softer regions through integrin binding, intercellular junc-
tions and the action of myosin motors are then able to
contract neighbouring cells resulting in collective movement
to firmer ground [91]. These observations highlight the
need to think about both the inherent substrate stiffness
and also the underlying stiffness gradient. Recently, a
method of polymerization control has been developed to
allow the user control over a stiffness gradient of PAM gels,
using unreacted cross-linker and monomer in a prepolymer-
ized hydrogel sink resulting in a tunable matrix ranging from
0.5 to 8.2 kPa mm21. This allows for an in vitro model span-
ning the in vivo physiological and pathological range that
can facilitate investigation of a range of mechanical signals
on one surface [86]. Other studies have combined two bio-
material strategies to achieve tissue interface-like differentiation
of MSCs. By engineering a hydrogel at a stiffness in the
boundary of cartilage, but lower than that of bone, and com-
bining this in a modular system with an osteogenic
topographically patterned substrate, this approach enabled
anisotropic differentiation of MSCs from a single source
down chondrogenic and osteogenic lineages, similar to the
interface of articular cartilage and bone found at the end of
long bones [92].
Elucidating the mechanism behind what micro- and
nanoscale properties cells sense at the cell–material interface
of substrates of given stiffnesses has been a matter of some
debate. Differentiation of MSCs on polydimethylsiloxane
(PDMS) and PAM hydrogels of varying stiffness (0.1 kPa–
2.3 MPa) with a covalently attached collagen coating were
used to show that cell spreading and differentiation were
unaffected by differing PDMS stiffness, with MSCs commit-
ting to osteogenic lineages. PAM substrates of high elastic
modulus also exhibited osteogenic differentiation of MSCs,
whereas this potential was lost on softer PAM substrates,
decreased ERK/MAPK signalling was observed, suggesting
MSCs were unable to form stable focal adhesions at this
low modulus. Trappmann and colleagues used differences
in ECM tethering to explain this effect, pore size on PAM sub-
strates, but not PDMS, decreased almost twofold on soft
substrates, proposing that varying pore size alters collagen
tethering and thus local stiffness i.e. lower collagen anchoringdensity enhanced cell spreading and therefore differentiation
[93].
On the other hand, work from the Engler group system-
atically modulated porosity of PAM substrates, without
altering stiffness, to control ligand–substrate tethering.
MSCs were cultured on these substrates and stiffness was
indeed found to be the driving factor for cellular spreading
and differentiation. Varying the degree of ECM–protein
anchoring reaffirmed this indicating bulk stiffness of two-
dimensional matrices as the main driver of cell response,
irrespective of protein tethering and porosity [94].
Despite the exact rules for mechanical control remaining
to be fully resolved, elucidation of cell signalling is emerging.
Osteogenesis of MSCs on stiff substrates is regulated by the
nuclear translocation of Yes-associated protein and its tran-
scriptional co-activator (YAP and TAZ), which consequently
activates the osteogenic transcription factor runt-related tran-
scription factor 2 (RUNX2) [95]. Preserved nuclear
compartmentalization of YAP/TAZ is observed when
MSCs are cultured on stiff substrates for long culture periods
(approx. 10 days), meaning they lose the ability to respond to
softer matrices and remain committed to an osteogenic differ-
entiation profile, suggesting MSCs possess a mechanical
memory [95] (figure 3a). YAP/TAZ activation, until recently,
was thought to be exclusive to the Hippo signalling pathway
[96], however using PAM gels of various stiffness a recent
study highlighted its direct mechanical activation [50]. By
varying substrate stiffness it was found that if forces from
adhesion and/or the cytoskeleton are high enough (above
5 kPa) stress fibres reinforce the cytoskeleton, in turn,
mechanically coupling it to the nucleus. This provides a
direct mechanical link from focal adhesion to the nucleus,
leading to nuclear flattening, stretching of nuclear pores
and thereby increasing YAP nuclear import [50]. Therefore,
in stiff, osteogenic environments MSCs shuttle YAP to the
nucleus to activate mechanosensitive signalling pathways.
As substrate stiffness correlates to the expression and
localization of cadherins and integrins, and therefore cell–
cell and cell–matrix adhesions, this mechanosensitive
mechanism can be exploited to modulate biochemical signal-
ling [97–99]. One study highlighted this by using materials
modified to present adhesive peptide motifs to modulate
fate commitment in MSCs (figure 3). Co-presentation of the
N-cadherin adhesive sequence HAVDI, mimicking cell–cell
interactions, and the FN RGD sequence, mimicking cell–
ECM interactions, were integrated into hydrogels of tuned
matrix stiffness. Upon co-presentation on stiff 2D gels,
YAP/TAZ remains cytosolic, thereby preventing osteogenic
lineage commitment. However, when the HAVDI motif is
removed and MSCs are thus exposed to an environment
with more ECM-like interactions, YAP/TAZ translocates
and MSCs commit to osteogenesis [66]. Interestingly, how-
ever, things differ in three dimensions, when the HAV
motif (the conserved part of the HAVDI sequence) is pre-
sented to MSCs encapsulated within hyaluronic acid (HA)
gels, cells perceive this more cell–cell-like interface and
commit to chondrogenesis—chondrocytes typically live in
pairs and hence cell–cell interactions are crucial [64].
Mechanical memory may have importance and impli-
cations for cell–material interactions, but also for clinical
use. MicroRNAs (miRNAs) are short, single-stranded, non-
coding RNAs. They bind one or more messenger RNA
(mRNA) and therefore regulate protein expression; typically,
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protein by binding the mRNA sequence [100]. MiRNA21, a
known regulator of fibrosis, is found to be elevated on stiff
substrates (such as tissue culture plastic) compared to softer
substrates (such as hydrogels). Elevated levels of miRNA21
repress mRNAs coding for proteins involved in anti-fibrotic
actions [101]. MSCs with elevated miRNA21 levels cultured
on stiff substrates (approx. 100 kPa), retain mechanical
memory for several passages once moved to soft hydrogels
(15 kPa). Fibrotic scarring is a major clinical problem, there-
fore MSC mechanical memory has clinical implications
when considering use for transplantation. It should be con-
sidered during pre-culture of MSCs, stiff substrates should
be avoided [101]. MiRNA21 also targets several proteins
involved in osteogenesis, such as SMA Small, MAD mothers
against decapentaplegic 7, SMAD7, and SRY sex determining
region Y-box2, SOX2. When MSCs with reduced miRNA21
expression are pre-cultured on soft substrates, they show
more osteogenic potential that those exposed to stiff sub-
strates, this suggests that lineage potential may be reduced
by the onset of a fibrotic programme [101].
Recently, a more counterintuitive mechanism of stiffness
related integrin–ligand interactions has emerged. The ‘mol-
ecular clutch model’ has long been proposed to explain
actin cytoskeleton and cell migration dynamics and has
now been employed to explain cell mechanotransduction
[102]. Using gels with controllable rigidity and ECM ligand
(RGD) spacing, it was shown that at low stiffness, close to
that of some of the softer body tissues (greater than 5 kPa),
when spacing between ligands was increased, focal adhesion
growth also increased. Remarkably, at higher stiffness ranges
typical of many body tissues, increased RGD spacing lead to
focal adhesion collapse. At 30 kPa the rigidity threshold was
found at around 100 nm RGD spacing, and at 150 kPa focal
adhesion collapse was found at 50 nm spacing. Above this
stiffness range, i.e. that of tissue culture plastic, conventional
rules apply—increased ligand density is required for
adhesion formation. However, for these more physiological
stiffnesses, the molecular clutch can be employed, that is,
ligand spacing is not via direct sensing, but instead individ-
ual integrin–ECM ligands (or ligand–cell adhesion
molecule) act as the ‘molecular clutches’ and as force load
increases more clutches are recruited, up to a threshold
value. The recruitment of more clutches redistributes the
force load among them, thus reducing the total force
each individual clutch is exposed to. When the threshold
recruitment is reached at high stiffness and increased spa-
cing, no further distribution can occur and the adhesion
collapses [103].
Other key stiffness-related mechanisms are also becoming
elucidated with the use of biomaterial strategies. In 2013
Swift et al. linked the mechanical tension exerted on a cell
through tissue specificity and ECM stiffness to changes in
transcriptional programmes. They proposed a model sup-
porting a physical link between the nucleus and mechanical
properties of the extracellular environment, whereby tension
from the ECM lead to biophysical changes in the cell cytoske-
leton on the nucleus [104]. Cells discern, translate and
transmit mechanical cues biochemically through mechano-
sensitive receptor-mediated signalling pathways [105], and
alternatively cell–cell and cell–ECM interactions are interwo-
ven with adhesion and filament networks to transmit forces.
Further, cytoskeletal rearrangement due to substrate stiffnesscan distort the nuclear envelope and therefore alter chromo-
somal positioning within the nucleus, altering the spatial
access of transcriptional regulators to distinct chromatin
sites [51]. Swift et al. showed that environmental stiffness
can change the transcription of the gene LMNA, and the stab-
ility of its protein lamin-A. In response to increased cellular
tension, turnover of lamin-A is reduced leading to physical
stiffening of the nucleus and stabilization of the nuclear
lamina and chromatin, and thus accumulation of YAP [104].
To describe how the cytoskeleton can transmit such
forces, elegant, tension based, cell-tensegrity models have
been proposed by Inger [106–108]. His group have illustrated
direct mechanical connection from integrins to the nucleo-
plasm [109] and, indeed, mechanical interconnection
between the chromosomes [110]. Further evidence of direct
cytoskeletal–nucleoskeletal coupling can be evidenced
through linkers of cytoskeleton and nucleoskeleton (LINCs
[111]) and also matrix attachment regions (MARs) between
the nuclear lamins and the telomeric regions of the chromo-
somes [112]. Using magnetic integrin stimulation (magnetic
nanoparticles coupled to integrin receptors with applied
magnetic fields—magnetic twisting cytometry), Inger and
colleagues have been able to show that integrin twisting
can distort the nucleus [113,114].
The last decade has focused heavily on tuning and defin-
ing matrix stiffness of biomaterial niches; it has been a key
facet in controlling cellular fate through traction forces. How-
ever, what is often neglected is that tissues and organs of the
body are often not purely elastic. Non-degradable hydrogel
systems capture some aspects of the physiological ECM
environment, however reconstituted ECMs such as collagen
and fibrin, and tissues such as adipose tissues, brain, liver,
fracture haematoma, and the soft callus of regenerating
bone, are all temporally viscoelastic [115]. The microenviron-
ment can either store (elasticity) or dissipate (viscosity)
cellular forces, thus impacting interacting cells. As both inves-
tigative and fabrication techniques progress exploration into
three-dimensional matrices has pushed the field to more bio-
mimetic systems, with strain exertion differing by almost an
order of magnitude between two- and three-dimensional cul-
tures (3–4% in two dimensions, 20–30% in three dimensions)
[115–117], this should become a key caveat for ‘humanized’
in vitro modelling systems.
Because of this, there is now focus on the effects of three-
dimensional matrices on MSC differentiation that go beyond
bulk material mechanical properties. MSCs encapsulated in
alginate of varied stiffness (2.5–110 kPa), presenting RGD
motifs at various clustering densities, highlighted that stiff
substrates that hindered cell spreading still enabled osteo-
genic commitment. Hence, rather than cell morphology it is
the cells ability to recognize and cluster adhesion ligands,
thus generating traction forces, that drives cell fate [118].
This supports the premise, in three-dimensions, that cells
‘sense’ differing stiffness as differing adhesion-ligand
presentations.
Another key example combines both three-dimensional
culture with matrix degradability; a tuneable HA based
system that either permits or prevents cell-mediated degra-
dation was used to show cell fate is morphology-independent
when the matrix is degradable, but is instead directed by
cell-mediated traction forces. Local degradability allowed
cells entrapped in gels to reach otherwise unavailable
adhesive ligands, rearranging their cytoskeletal structure to
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commitment, irrespective of morphology or bulk matrix stiff-
ness [119]. These two studies suggest that cell-mediated
traction forces are influenced by the cells’ ability to locally
deform rigid substrates but show that bulk matrix rigidity
directly [118] or indirectly [119] regulates cell fate.
Fibre architecture has also been highlighted as a mechan-
ism for transducing matrix stiffness, where lower fibre
stiffness allow cells to recruit nearby fibres and correlates
with enhanced cell spreading and proliferation [120].
Dynamic properties such as matrix degradation and fibre
recruitment establish the fourth dimension into three-
dimensional matrices [121]. The ECM and niche are naturally
dynamic microenvironments, and hence the introduction of
time more accurately captures in vivo-like mechanical behav-
iour, and is also important when considering MSC
mechanical memory [95]. The importance of mechanical
dynamics is further highlighted by a recent study, where con-
trolled stress-relaxation of substrates determined MSC fate
changes; the rate of the stress relaxation determined the
degree of mechanical matrix remodelling. In rapidly relaxing
hydrogels, MSCs undergo osteogenesis due to the strain the
cells exert on the hydrogel introducing an initial level of intra-
cellular stress that eases with matrix reorganization. This
facilitates integrin clustering which in turn generates tension
allowing the cell to ‘sense’ the stiffness of the material; lead-
ing to morphology changes and bone matrix formation [115].
The incorporation of these dynamic features into three-
dimensional matrices will be critical in understanding and
harnessing the cellular response to mechanical properties.2.3. Chemistry
Chemistry-based strategies to engineering substrates have
also been employed, changes in cell adhesion to substrates
can be controlled by manipulation of properties of
materials such as surface wettability [122,123], and
through control of surface properties that influence protein
adsorption and thus are able to enhance and control cell
adhesive properties [37,124,125]. It has been shown that
different chemical groups can influence MSC fate, for
example, poly(ethylene glycol) (PEG) hydrogels functiona-
lized with small molecule chemical groups are able to
direct adipogenesis with hydrophobic t-butyl groups,
and osteogenesis with charged phosphate groups [126].
However, organic chemistry is beginning to offer new
strategies for biomaterial synthesis and control, for
example developments in click-chemistry [127–129]
and GF tethering techniques [130,131], it offers a diverse
toolbox for precise functionalisation of substrates.
Commonly used PEG hydrogels can be modified to
contain photodegradable cross linkers, allowing the user
post-gelation control over substrate properties such as gel
conformation and biochemical composition with MSCs
in situ. Photodegradation of the hydrogel network changes
the physical three-dimensional microenvironment of the
encapsulated cells and can lead to migration or lineage com-
mitment [132]. Incorporation of light-controlled binding
moieties, such as RGD, can also lead to dynamic control
over cell fate; hydrogels were functionalized with pendular
RGD motifs that are dynamically cleaved by a light stimuli,
decreasing availability for adhesion formation and leading
MSCs to commit to chondrogenesis [132]. Additional studiesapply other click-chemistry strategies to design protease-
degradable PEG hydrogels, these incorporate locally
sequestered GFs only released upon cell infiltration [133].
Similarly, enzymatic activation was exploited in a 2D PEG
based system. Here RGD groups were attached to a low-
adhesion PEG or Fmoc (fluorenylmethyloxycarbonyl), the
‘blocking group’ via an elastase cleavable linker, with the
blocking group preventing easy access to the RGD moieties
for cell integrins. With the blocking group in place, adhesion
and intracellular tension were lowered sufficiently to support
MSC self-renewal. However, upon elastase cleavage of the
dialanine (AA) linker, cells could access the RGD more
easily, form larger adhesions supporting greater intracellular
tension, driving osteogenic differentiation [134].
Other chemical approaches aim to create ECM-mimetic
materials, the FN RGD adhesion domain has been incorpor-
ated into many materials, however, when it is presented with
its synergy domain PHSRN it enhances the affinity of integrin
binding over 40-fold [135]. This FN fragment, FNIII7-10, can
be engineered to retain the native spacing between the syner-
gistic sites, which increases specifically the binding of
integrin a5b1. Surfaces engineered that contained RGD-
only, or failed to control site distances, showed a decrease
in cell adhesion [136]. This control over integrin binding
using FN fragments was found to promote osteoblast differ-
entiation in vitro, and improve osteointegration of titanium
implants in vivo [136–138]. Such adhesive group grafting
has similarly been used to functionalize titanium. Here, the
RGD motif was presented with PHSRN to induce efficient
osteogenesis of MSCs [75]. Titanium is the gold standard
material for hip replacements and many other orthopaedic
materials, and hence this study provides an example of
how materials already employed in a clinical setting could
be simply functionalized to create cell instructive materials
that may increase implant efficacy.
In addition to its integrin binding domains, FN also con-
tains a highly promiscuous GF binding domain in its 12th
to 14th type III repeats [139] (figure 4a), meaning this mol-
ecule could also be exploited as an approach to deliver GFs.
GFs have been widely employed in the clinic, due to their
capacity to regulate cell growth, healing and stem cell
differentiation, however soluble GF administration usually
means application of supraphysiological doses which can
lead to serious off-target side effects [140]. One study engin-
eered a recombinant FN fragment to contain both the
integrin binding and the GF affinity domain bound to a
fibrin matrix, leading to potent synergistic signalling
through recruitment of integrins and GF receptors to
adhesion domains. By incorporating platelet-derived
growth factor (PDGF) and bone morphogenic protein 2
(BMP-2), they found the system could promote both
wound repair and bone growth [141]. This recombinant
protein approach to exploit FN integrin-binding and GF-
sequestering domains is employed as upon adsorption to
synthetic materials FN typically adopts a globular confor-
mation, concealing these binding sites. However work by
our group found that upon FN adsorption, the polymer
poly (ethyl acrylate) (PEA) causes spontaneous unfolding
of FN leading to assembly into nanonetworks, thus expos-
ing cell binding and GF binding domains (figure 4b)
[142]. This approach allowed absorption of BMP-2 at
approximately 300-fold lower dose than the current gold
standard application for bone repair. This simple
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Figure 4. Fibronectin (FN) nanonetwork formation and growth factor (GF) presentation. (a) FN has three types of domains involved in FN–FN interactions (I1 – 5), GF
sequestration (III12 – 14) and integrin binding (III9 – 10). (b) Atomic force microscopy (AFM) images after FN adsorption shows spontaneous formation of FN nanonet-
works on PEA, but not PMA which results in globular FN aggregates. Sequential adsorption of growth factor (here BMP-2, at 25 ng ml21) shows interactions of
BMP-2 with FN fibrils on PEA, but not PMA, due to an open molecular conformation exposing the key GF binding domain. The proximity of the GF binding and
integrin binding domain on FN molecules in networks leads to synergistic integrin and GF receptor signalling. (c) Conventional solubilized GF delivery (right) nor-
mally requires high dosages, making it less efficient than ECM-bound (or solid-phase presenting) systems (left) that may use several orders of magnitude lower
dosages, allowing efficient, targeted delivery that also has the potential to facilitate cross-talk between integrins and growth factor receptors. (a) Adapted from and
(b) taken from reference [130].& The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. Distributed under a
Creative Commons Attribution License 4.0 (CC BY). (c) Adapted from reference [65]. (Online version in colour.)
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of BMP-2 on the FN material-driven networks, and was
shown to drive significant bone regeneration in a critical
size defect in vivo [130]. This system has also been used to
coat titanium implants to present ultralow doses of BMP-
7, with the aim to improve the bio-integration of titanium
implants [143], and further to this, by tethering vascular
endothelial growth factor (VEGF) improved vascularization
of biomaterial scaffolds was achieved in vivo [144].Immobilized GF technologies not only permit lower
doses of the GF to be employed (thus being more cost effec-
tive than solubilized GF delivery) but as many of these
ligands act at interfaces in vivo, immobilization also permits
a more biomimetic recapitulation of stem cell niches
[131,145] (figure 4c). Controlled tethering of such ligands to
synthetic materials has proved difficult [146], as non-specific
cross-linking may compromise the molecules bioactivity and
further issues in controlling the amount, stability and cellular
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by Fan et al., were a poly(ethylene oxide) (PEO) based co-
polymer was used to covalently tether epidermal growth
factor (EGF) to the substrate, a GF associated with tissue
repair. Specific tethering at the N-terminus retained EGF
bioactivity but restricted it to the surface. EGF tethering led
to signalling through its receptor EGFR, in a manner akin
to physiological-like matrix-embedded EGF, where EGFR is
stimulated but not internalized [147]. Another striking
example of protein tethering is immobilized leukaemia
inhibitory factor (LIF), an essential protein for ESC self-
renewal, to maleic anhydride copolymer thin-film coatings.
Here, they showed retention of pluripotency for at least
two weeks in absence of soluble LIF in culture media
(i.e. standard ESC feeder-free culture conditions) [131].
More recently, block copolymer micellar nanolithography
was used to coat substrates with evenly spaced and tuneable
arrays of gold nanoparticles functionalized to carry BMP-2
molecules. This system allows precise control over the nanos-
cale distribution of the BMP-2, with one BMP-2 molecule/
nanoparticle, both the local amount and the distance between
BMP-2 anchor points can be varied. Here it was found that
immobilized BMP-2 increased intracellular Smad-signalling
compared to if the GF was administered soluble in the
media, even at concentrations as low as 0.2 ng cm22
Smad-dependent signalling was observed [148]. This system
permits sustained local delivery of BMP-2 or other GFs, and
allows the precise study of the effects of GF density and
spacing on intracellular signalling.3. Artificial stem cell niches for self-renewal
Using biomaterial interfaces, mechanisms for MSC differen-
tiation are beginning to be well understood. However,
understanding MSC self-renewal in vitro is of growing impor-
tance. MSCs are increasingly used in tissue engineering
strategies, but are also being studied for their tumour-homing
abilities fordrugdelivery [5]andasanti-inflammatories tomodu-
lategraft-versus-hostdisease [8,9,14]. To support this,MSCsneed
to be isolated and expanded in vitro, this presents a challenge due
to loss of self-renewal capacity on normal tissue culture plastic.
In vivo this homeostasis between self-renewal and differ-
entiation, quiescence and proliferation, is tightly controlled
by many factors from the niche (figure 1). Through modu-
lation of biomaterial properties discussed above, in vitro
stem cell self-renewal is being investigated. As noted earlier,
nanotopographies have been employed with well-defined
patterning, an ordered square pattern leads to retained multi-
potency of MSC markers over long culture periods [44].
Muscle stem cell regenerative capacity has been maintained
in culture microenvironments that mimic the native stiffness
of muscle (12 kPa) [149], and simple chemical modification
of glass substrates have been used to present functional
groups that maintain MSC phenotype [150]. It is notable
that control of MSC self-renewal by stiffness remains elusive.
However, it has been demonstrated that environments with
homogeneous stiffness do not support cell growth as well
as heterogeneous environments. Using photodegradable
hydrogels, it has been shown that disorganized patterns of
matrix mechanics lead to cytoskeletal disruption, decreased
cell spreading and prolonged expression of MSC-related
marker proteins [151]. Further, nanoparticle basedapproaches have been used to maintain MSC phenotype.
Using super paramagnetic nanoparticles, MSCs were magne-
tically levitated into spheroids within collagen type I gels. In
this three-dimensional niche, they remained quiescent and
expressed niche/MSC markers such as nestin and stro-1.
Further, using a simple wound healing model that involved
placing the spheroid-niches above monolayers of different
phenotypes (fibroblast, osteoblast, chondrocyte) that were
subsequently scratched, the cells could respond to the regen-
erative demand with migration, differentiation and
engraftment into the required phenotype [152]. It is impor-
tant to note that if intact, non-scratched, monolayers were
used, the MSCs in the niches remained quiescent. This is a
key observation of a regeneration responsive, but otherwise
quiescent three-dimensional in vitro niche.
Understanding the mechanisms behind adult stem cell, and
specifically MSC, self-renewal has been somewhat limited. For
MSCs, self-renewal requires an intermediate adhesion state that
suppresses differentiation and allows for long-term growth in
vitro. As highlighted by many biomaterial strategies, osteogen-
esis of MSCs requires large adhesions that support high
intracellular tension [43,45], with adipogenesis opposing this,
occurring when adhesion is weak and tension low [39,40]; con-
ditions favouring MSC self-renewal sit mid-way between these
two fates. However, as these conditions also favour fibroblast
formation, it has been hard to achieve this in culture [32,65].
MSC self-renewal mechanisms are emerging as rather
different than the better known embryonic self-renewal mech-
anisms using NANOG, SOX2 and OCT4 [153], to dissect MSC
self-renewal biomaterial strategies are being developed, for
example the highly-ordered square (SQ) nanotopography
[43,44,154]. Mitogen activated protein kinases (MAPKs) have
emerged as the ‘switch’ that controls MSC growth and differ-
entiation [155], extracellular signal-related kinase (ERK1/2) is
a known key regulator of proliferation and growth, and along
with other MAPKs is also known to act in cell cycle regulation.
ERK1/2 is also implicated in phosphorylation of lineage defin-
ing transcription factors, for example, for osteogenesis [155]. It
has been proposed in HSCs and pluripotent cells that the tran-
sition from early to late G1 phase is crucial for self-renewal
[156–160]. Using nanotopographies, mitogenic factor cyclin
dependent kinase 6 (CDK6), which is involved in G1-S tran-
sition, was found to be upregulated in proliferating MSCs
[33], and has also been shown to inhibit bone morphogenetic
protein (BMP)-induced osteogenesis [161], this suggests a
role in both growth progression and differentiation restriction.
While MSCs undergoing material-controlled self-renewal
have normal growth and proliferation rates, the MSCs spend
longer in G0/G1 and less time in G2 [162]. The increase in
G1 phase in cells is accompanied by the repression of cyclin
D1, which forms a complex with cell division cycle 2 protein
(cdc2) to drive cell cycle progression [163]. Similar cell cycle
control has been reported in neural stem cells [160], while plur-
ipotent stem cells have shorter G1 phases [157–159]. It is
notable that when undergoing material-controlled osteogen-
esis, the expression of E2F transcription factor 1 (E2F-1),
which promotes G1 to S phase transition, is decreased [164],
and phosphorylated retinoblastoma protein (pRB), which
blocks the entry from theG1 to the S phase andwhich is associ-
ated with the activation of RUNX2 [165], is upregulated. This
suggests that MSCs regulate cell cycle to both slow growth
(osteoblasts are slow growing cells while MSCs are fast grow-
ing cells) and prime osteogenic sensitivity.
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gineering techniques are moving towards allowing
deconstruction and reconstruction of these multifaceted sys-
tems. To shed light on mechanisms used by stem cells in their
niches, oneapproach is to simplify the system.Todo this,micro-
arrayplatformshavebeendeveloped that allowscreeningof the
effects of unique combinations ofmultiplemicroenvironmental
signals on stem cell fate. Using robotic spotting technologies
mixtures of protein cues, such as ECMcomponents, niche inter-
action ligands and other signalling proteins, can be presented
and analysed at the single-cell level [166,167]. One example cul-
tured human neural precursors on protein printed arrays and
found cells remained in an undifferentiated state only when
stimulated by two morphogens in concert, Wnt and Notch
[168]. This approach has also been used to investigate ligands
involved in the conversion of mammary epithelial cells to
myoepithelial or luminal epithelial fates [169]. More recently,
Roch et al. presented ligand components of the bone marrow
niche and identified candidates important for HSC mainten-
ance, presented to HSCs and using single-cell analysis, they
were able to define gene expression signatures of HSCs as
they differentiated into multipotent progenitors (MPPs) [170].
Similar microarray platforms have been developed to
screen for self-renewal promoting materials discovery. Both
human embryonic and induced pluripotent stem cells
(hPSC) have the ability to self-renew indefinitely in culture,
and hence hold great promise for drug discovery and regen-
erative medicine [171–174]. However, present culture
methods for clonal expansion of these cells is suboptimal—
involving mouse embryonic fibroblast feeder layers or
animal derived feeder-free culture systems (such as Matrigel)
which are inefficient, prone to both batch-to-batch variability
and xenogenic contaminants [123,175,176]. Defined culture
conditions need to be established to produce safer and
more biomedically useful hPSCs. Combinatorial polymer
libraries were first posed in 1997 [177] and in 2004 on-slide
synthesis of polymer microarrays was achieved by Langer’s
group [178]. Rapid synthesis of acrylate based polymers is
achieved by monomer combinatorial mixing printed onto
hydrogel-coated slides, which then undergo ultraviolet-
photoinitiated free-radical polymerization [122,178,179].
Such polymer microarrays were subsequently used to
screen a first-generation library of 496 acrylate polymer com-
binations [122]. Assessment of clonal growth, expression of
key pluripotency marker OCT4, and characterization of sur-
face properties (such as wettability, elastic modulus and
surface roughness) were quantified using high-throughput
methodologies. Through mapping stem cell behaviour to
material properties, surface wettability was found to be the
strongest modulator of colony forming frequency, and
engagement of integrins aVb3 and aVb5 with adsorbed vitro-
nectin promoted hPSC self-renewal for long-term culture
periods [122]. Scalability of hit materials was not demon-
strated in this study [122], however, it is envisioned how
such synthetic, readily synthesized monomers could be
scaled up to create cell cultureware, removing some of the
current hurdles for biomedical translation of these cells.4. Future and conclusion
Many of the approaches discussed above are reductionist in
nature and have been key to elucidating and understandingkey mechanisms for how cells sense and respond to
their complex microenvironment, however, while these
approaches are easily scalable and robust, they lack biologi-
cal functionality. Recent material strategies are now
beginning to re-build the complexity of the niche in vitro to
create more tissue-like systems, as there is a strong need for
more humanized, NATs (bioengineered, cellular, scaffolds,
on-chip systems) for drug discovery, disease modelling and
regenerative medicine.
For example, one study designed a synthetic hydrogel
(PEG based) system to define the ECM parameters that
govern ISC expansion and organoid formation. Organoid for-
mation is through self-organization of stem cells into
structures that resemble their native multicellular architecture
and many of their functional features. Here, by designing a
matrix that was mechanically dynamic, it allowed for optimal
ISC expansion (stiff substrate, FN-based adhesion), and
subsequently for differentiation and intestinal organoid for-
mation (soft-matrix, laminin-based adhesion). This dynamic
substrate design could thus support the need for the chan-
ging mechanical environments throughout the native
cellular evolution during organ development [180]. Another
key example of intestinal organoid formation was recently
developed also using a modular PEG hydrogel system, here
adhesive peptides are bound to one fraction of the four-
armed PEG molecule to mimic basement membrane inter-
actions, the unconjugated arms are then cross-linked with a
protease-cleavable peptide to form the hydrogel. Both the
adhesive sequences and the cross-linking peptides can be
exchanged, and by varying the PEG concentration, matrix
stiffness is also tuneable. hPSC were seeded into gels to
form intestinal organoids, and upon implantation into
mechanically injured colons of immunocompromised mice
could enhance healing of the defects [181]. These fully
synthetic systems offer well-defined alternatives to animal-
derived platforms (such as Matrigel), expanding applicability
as complex models for both potential therapeutic
applications, and clinical and industrial research.
Further to organoids, organ-on-a-chip (OOC) platforms
seek to recapitulate the multifaceted tissue-specific cellular
microenvironment in three-dimensional settings for a given
organ system. OOC aims not to build a whole living organ,
but to establish a minimally functional unit that is represen-
tative of aspects of human physiology in a controlled
system [182]. Several limitations posed by organoid systems
which influence organ development and function during
development and disease can be addressed with these
microfluidic OOC systems—for example parameters such
as physical forces including fluid shear stress [183,184],
mechanical compression [185,186] and electrical stimulation
[187]. OOC allows for recreation of tissue interfaces
(e.g. lung alveolus–capillary [186], blood–brain barrier [188])
multicellular compilations that enable communication between
multiple cell types (e.g. liver hepatocytes and fibroblasts
[189,190]) and the integration of individual OOCs through
microfluidic channels tomimic physiological organ subsystems
(e.g. liver–pancreas [191], liver–heart [192]). By guiding or
situating collections of cells that can assemble into
three-dimensional structures OOCs can represent simplified
yet realistic models of organ-level systems, and offer functional
read-outs that suit the intended application. Systems such as
these can model healthy and diseased development and
behaviours, offering again more realistic models for drug
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that their use alongside clinical trialswill help realize a precision
medicine approach, where individual patients can be tested, or
important differences in varied patient cohorts (such as sex, age,
ethnicity, other pathology) could be considered and trials
optimized for specific patient biology [182].
On the other hand, microwell formats that recapitulate
cell–cell and cell–matrix interactions typical of stem cell
niches will be valuable for analysis of heterogeneous popu-
lations of stem cells at the single cell level. Integration of
material technologies and protein patterning will be crucial
in fabrication of microwell arrays, these will allow high
throughput screens to identify ECM molecules relevant to
‘niche-like’ regulation. By developing arrays that mimic
cell–cell interactions through peptide presentation, single or
combinations of molecules can be identified that induce
effects on cell behaviours, such as self-renewal and lineage
commitment [167,170]. Typical cell–cell interaction studies
rely on co-culture of two or more cell types together that
not only make it difficult to distinguish the key molecular
effectors, but also encounter further problems such as com-
promised media types, multiple patient sources, and
biological variation. It is envisioned high-throughput
approaches could be developed to incorporate many of the
biophysical and biochemical properties discussed throughout
this review.
Technologies such as these will prove valuable for the
pharmaceutical industry, as although in recent decades
advances in the molecular understanding of diseases has
underpinned new potential therapeutic targets there is a
lack of corresponding increase in drug discovery and man-
ufacture. This is irrespective of substantial increases in
research and development investment, which led to a
‘volume research’ approach using new genomic and high-
throughput technological approaches, and yet productivity
has remained static [193]. This frustration led AstraZeneca
to report that from 2011 to 2016, 66% of its small molecule
projects failed; critically only 23% before clinical trials (i.e.
cheap fails) [26]. This suggests that drug discovery has
become more challenging, but also demonstrates a lack of
ability to predict success at the pre-clinical testing stage.
Further to this, although animal models are widely used
for both drug discovery and toxicology screening, it is
notable that 43% of new drug fails are not predicted by
the in vitro and pre-clinical in vivo screens. It is envisioned
that technologies such as many discussed above will solve
these issues, by engineering validated NAT models that
can more readily predict drug targeting and tissue doseexposure, and hence leads with high risk of failure can be
dropped quickly—before expensive clinical trial stages. As
discussed above, biomaterial engineered systems can
easily introduce complex physiological-like parameters,
removing problems of overly simple in vitro cell lines and
in vivo models (non-human, animal based). Currently, reg-
ulators are encouraging the development of tissue models,
such as organoids, to help provide ‘humanized’ data along-
side traditional in vivo data [194]. Further, the banning of
animal testing in toxicology screenings for e.g. cosmetics
in the UK, has driven the use of NAT models for toxicologi-
cal assessment. Several bioengineered approaches have
emerged for skin/eye irritation and phototoxicity, for
example EPISKINTM, SkinEthic RTE and EpiDermTM
[195–197].
NAT development will also play a key role in the
advancement of the use of stem cells for clinical applications
in regenerative medicine. Current culture systems rely on
non-human (xeno) serums in culture mediums or feeder
layers to support SC survival and expansion. However,
these xeno systems can induce as immune response upon
clinical transplantation, for example, FBS is a potential
source of pathogens, such as endogenous retroviruses and
xenoepitopes, and batches of the feeder layer Matrigel have
been found to be contaminated with lactate-dehydrogenase-
elevating virus (LDV). Further to this, xeno-derived
components suffer greatly from batch-to-batch variability.
This has driven searches for serum-free and feeder-free cul-
ture systems, although current systems contain several
recombinant proteins or inhibitors whose long-term effects
are yet to be understood. Suggesting further, the need for
more humanized models that remove contaminating animal
factors, it is highly anticipated that this can be approached
by the advancement in understanding of the stem cell niche
with biomaterial and biofabricated systems.
In conclusion, the future for materials as biological tools
to dissect stem cell functions, as the building blocks to
develop NATs to accelerate drug screening and to underpin
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